EG 427 is a biotechnology company developing genetic medicine solutions for chronic neurological diseases using non-replicating HSV-1 vector technology.

FIRE1 is a connected medical device solutions company focused on developing a heart failure management platform that enables patient self-management and reduces healthcare burdens.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Mylight150 is a cleantech company specializing in solar power solutions, including solar panels, virtual electricity storage, and energy management systems, aiming to make solar energy a primary source in Europe.

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.